Effectiveness of Intermittent Pneumatic Compression Devices for Venous Thromboembolism Prophylaxis in High-Risk Surgical Patients: A Systematic Review

• Published in: The Journal of arthroplasty Vol. 31; no. 2; pp. 524 - 532
• Main Authors: Pavon, Juliessa M., Adam, Soheir S., Razouki, Zayd A., McDuffie, Jennifer R., Lachiewicz, Paul F., Kosinski, Andrzej S., Beadles, Christopher A., Ortel, Thomas L., Nagi, Avishek, Williams, John W.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.02.2016
• Subjects: anticoagulation; Arthroplasty - adverse effects; Hemorrhage - prevention & control; Humans; Intermittent Pneumatic Compression Devices; joint arthroplasty; Observational Studies as Topic; Orthopedics; Randomized Controlled Trials as Topic; surgery; Venous Thromboembolism - etiology; Venous Thromboembolism - prevention & control; venous thromboembolism prophylaxis; Venous Thrombosis - etiology; Venous Thrombosis - prevention & control; joint arthroplasty; anticoagulation; intermittent pneumatic compression devices; venous thromboembolism prophylaxis; surgery
• ISSN: 0883-5403; 1532-8406
• DOI: 10.1016/j.arth.2015.09.043

Thromboprophylaxis regimens include pharmacologic and mechanical options such as intermittent pneumatic compression devices (IPCDs). There are a wide variety of IPCDs available, but it is uncertain if they vary in effectiveness or ease of use. This is a systematic review of the comparative effectiveness of IPCDs for selected outcomes (mortality, venous thromboembolism [VTE], symptomatic or asymptomatic deep vein thrombosis, major bleeding, ease of use, and adherence) in postoperative surgical patients. We searched MEDLINE (via PubMed), Embase, CINAHL, and Cochrane CENTRAL from January 1, 1995, to October 30, 2014, for randomized controlled trials, as well as relevant observational studies on ease of use and adherence. We identified 14 eligible randomized controlled trials (2633 subjects) and 3 eligible observational studies (1724 subjects); most were conducted in joint arthroplasty patients. Intermittent pneumatic compression devices were comparable to anticoagulation for major clinical outcomes (VTE: risk ratio, 1.39; 95% confidence interval, 0.73-2.64). Limited data suggest that concurrent use of anticoagulation with IPCD may lower VTE risk compared with anticoagulation alone, and that IPCD compared with anticoagulation may lower major bleeding risk. Subgroup analyses did not show significant differences by device location, mode of inflation, or risk of bias elements. There were no consistent associations between IPCDs and ease of use or adherence. Intermittent pneumatic compression devices are appropriate for VTE thromboprophylaxis when used in accordance with current clinical guidelines. The current evidence base to guide selection of a specific device or type of device is limited.